Xiaolin Wu

Ms. Xiaolin Wu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2020 in Marine Drugs
Verified
Journal Article
Open access
PDF file
YLYingjuan Liu
Yingjuan Liu
XWXiaolin Wu
Xiaolin Wu
WJWeihua Jin
Weihua Jin
YGYunliang Guo
Yunliang Guo
The water-soluble polysaccharide EP2, from Enteromorpha prolifera, belongs to the group of polysaccharides known as glucuronoxylorhamnan, which mainly contains glucuronic acid (GlcA), xylose (Xyl), and rhamnose (Rha). The aim of this study was to detect the immunomodulatory effects of EP2 on RAW 264.7 macrophages and cyclophosphamide (CYP)-induced immunosuppression mouse models. The cells were treated with EP2 for different time periods (0, 0.5, 1, 3, and 6 h). The results showed that EP2 promoted nitric oxide production and up-regulated the expression of pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α, in a time-dependent manner. Furthermore, we found that EP2-activated iNOS, COX2, and NLRP3 inflammasomes, and the TLR4/MAPK/NF-κB signaling pathway played an important role. Moreover, EP2 significantly increased the body weight, spleen index, thymus index, inflammatory cell counts, and the levels of IL-1β, IL-6, and TNF-α in CYP-induced immunosuppression mouse models. These results indicate that EP2 might be a potential immunomodulatory drug and provide the scientific basis for the comprehensive utilization and evaluation of E. prolifera in future applications.

26 February 2021 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YLYingjuan Liu
Yingjuan Liu
XWXiaolin Wu
Xiaolin Wu
YWYue Wang
Yue Wang
YGYunliang Guo
Yunliang Guo